These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 16904810

  • 1. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.
    Rossner S, Sastre M, Bourne K, Lichtenthaler SF.
    Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810
    [Abstract] [Full Text] [Related]

  • 2. The transcription factor Yin Yang 1 is an activator of BACE1 expression.
    Nowak K, Lange-Dohna C, Zeitschel U, Günther A, Lüscher B, Robitzki A, Perez-Polo R, Rossner S.
    J Neurochem; 2006 Mar; 96(6):1696-707. PubMed ID: 16539685
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.
    Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR.
    J Neurosci Res; 2007 May 01; 85(6):1194-204. PubMed ID: 17385716
    [Abstract] [Full Text] [Related]

  • 4. Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme.
    Rossner S, Lange-Dohna C, Zeitschel U, Perez-Polo JR.
    J Neurochem; 2005 Jan 01; 92(2):226-34. PubMed ID: 15663471
    [Abstract] [Full Text] [Related]

  • 5. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
    Cho HJ, Jin SM, Youn HD, Huh K, Mook-Jung I.
    Aging Cell; 2008 Mar 01; 7(2):137-47. PubMed ID: 18081741
    [Abstract] [Full Text] [Related]

  • 6. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
    Hartlage-Rübsamen M, Zeitschel U, Apelt J, Gärtner U, Franke H, Stahl T, Günther A, Schliebs R, Penkowa M, Bigl V, Rossner S.
    Glia; 2003 Jan 15; 41(2):169-79. PubMed ID: 12509807
    [Abstract] [Full Text] [Related]

  • 7. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
    Sun X, Wang Y, Qing H, Christensen MA, Liu Y, Zhou W, Tong Y, Xiao C, Huang Y, Zhang S, Liu X, Song W.
    FASEB J; 2005 May 15; 19(7):739-49. PubMed ID: 15857888
    [Abstract] [Full Text] [Related]

  • 8. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
    Stockley JH, O'Neill C.
    Biochem Soc Trans; 2007 Jun 15; 35(Pt 3):574-6. PubMed ID: 17511655
    [Abstract] [Full Text] [Related]

  • 9. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J, Ray WJ, Espeseth A, Simon A, Shi XP, Wolffe C, Getty K, Marine S, Stec E, Ferrer M, Strulovici B, Bartz S, Gates A, Xu M, Huang Q, Ma L, Shughrue P, Burchard J, Colussi D, Pietrak B, Kahana J, Beher D, Rosahl T, Shearman M, Hazuda D, Sachs AB, Koblan KS, Seabrook GR, Stone DJ.
    Proc Natl Acad Sci U S A; 2006 Nov 21; 103(47):17967-72. PubMed ID: 17098871
    [Abstract] [Full Text] [Related]

  • 10. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
    Züchner T, Perez-Polo JR, Schliebs R.
    J Neurosci Res; 2004 Jul 15; 77(2):250-7. PubMed ID: 15211591
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. BACE1 gene expression and protein degradation.
    Zhou W, Qing H, Tong Y, Song W.
    Ann N Y Acad Sci; 2004 Dec 15; 1035():49-67. PubMed ID: 15681800
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
    Wu G, Sankaranarayanan S, Hsieh SH, Simon AJ, Savage MJ.
    J Neurosci Res; 2011 Jun 15; 89(6):822-32. PubMed ID: 21433051
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
    Hampel H, Shen Y.
    Scand J Clin Lab Invest; 2009 Jun 15; 69(1):8-12. PubMed ID: 18609117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE, Thompson LA, Toyn JH, Marcin L, Barten DM, Marcinkeviciene J, Kopcho L, Kim Y, Lin A, Guss V, Burton C, Iben L, Polson C, Cantone J, Ford M, Drexler D, Fiedler T, Lentz KA, Grace JE, Kolb J, Corsa J, Pierdomenico M, Jones K, Olson RE, Macor JE, Albright CF.
    J Pharmacol Exp Ther; 2008 Aug 15; 326(2):502-13. PubMed ID: 18499745
    [Abstract] [Full Text] [Related]

  • 19. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S, Price EA, Wu G, Crouthamel MC, Shi XP, Tugusheva K, Tyler KX, Kahana J, Ellis J, Jin L, Steele T, Stachel S, Coburn C, Simon AJ.
    J Pharmacol Exp Ther; 2008 Mar 15; 324(3):957-69. PubMed ID: 18156464
    [Abstract] [Full Text] [Related]

  • 20. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
    Clarimón J, Bertranpetit J, Calafell F, Boada M, Tàrraga L, Comas D.
    J Neurol; 2003 Aug 15; 250(8):956-61. PubMed ID: 12928915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.